Abbott Laboratories stock pre-market: EUR 88.06, prior close EUR 87.69 on October 7, 2026
Published on 10/08/2026 at 08:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Abbott Laboratories stock was at EUR 88.06 in pre-market trading at Lang & Schwarz at 8:20 a.m. CEST on October 8, 2026. The price was up 0.42 percent versus the prior close of EUR 87.69 on October 7, 2026.
Pre-market trading
Lang & Schwarz showed a bid of EUR 87.80 and an ask of EUR 88.32. The quoted price was above the previous session’s closing level, with the Xetra market still closed ahead of its 9:00 a.m. opening. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of Abbott Laboratories stock.
Recent Abbott development
Abbott announced on September 30, 2026, the U.S. commercial launch of SimpleScreen CRC, an FDA-approved blood-based colorectal cancer screening test for average-risk adults age 45 and older. The company said the test was developed and manufactured by Freenome and exclusively commercialized by Abbott. In a prespecified analysis, SimpleScreen CRC showed 81.1 percent overall sensitivity for colorectal cancer and 90.4 percent specificity for advanced colorectal neoplasia, according to the PR Newswire release.
